Affiliation:
1. Infectious Disease Service, New England Medical Center Hospital and the Peter Bent Brigham Hospital, Boston, Massachusetts 02111
Abstract
Silver sulfadiazine, at a concentration of 10 μg/ml when applied immediately after infection by
Herpesvirus hominis
, prevented the development of acute herpetic keratoconjunctivitis in rabbits. The efficacy was inversely related to the size of inoculum. Subclinical infections were observed in the drug-treated eyes.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference7 articles.
1. Baxter C. R. 1971. Topical use of 0.1% silver sulfadiazine p. 217-225. In H. C. Polk and H. H. Stone (ed.) Contemporary burn management. Little Brown and Co. Boston.
2. In vitro antiherpesviral activity of silver sulfadiazine;Chang T. W.;J. Infect. Dis.,1975
3. Inactivation of Treponema pallidum by silver sulfadiazine;Chang T. W.;Antimicrob. Agents Chemother.,1975
4. Inactivation of herpesvirus hominis type 1 and 2 by silver nitrate in vitro and in vivo;Coleman W. R.;Antimicrob. Agents Chemother.,1973
5. Silver sulfadiazine-new topical therapy for pseudomonas in burns;Fox L. L.;Arch. Surg.,1968
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献